RSS   Newsletter   Contact   Advertise with us

Celldex changes management team

Staff Writer | Hampton, N.J., USA | June 19, 2017
CelldexJune 19, 2017, Hampton, N.J., USA - Celldex Therapeutics, a clinical-stage biotech company, announced additions to the board of directors and senior management team.
Keith L. Brownlie was elected to the Company’s Board of Directors at Celldex’s 2017 Annual Meeting of Stockholders held yesterday.

Mr. Brownlie was employed by the accounting firm Ernst & Young LLP from 1974 to 2010, where he served as audit partner for numerous public companies and was the Life Sciences Industry Leader for the New York metropolitan area.

Sam Martin has been promoted to Senior Vice President and Chief Financial Officer, effective July 1, 2017.

Mr. Martin joined Celldex in April 2009 and currently serves as Vice President, Finance.

He will assume the responsibilities on June 30, 2017.

Sarah Cavanaugh has been promoted to Senior Vice President, Corporate Affairs and Administration.

Ms. Cavanaugh joined Celldex in August 2012 as Vice President of Investor Relations and Corporate Communications.

Ms. Cavanaugh will continue fulfilling those responsibilities and will assume leadership for human resources, employee relations, organizational development and internal communications.